Identification
Personal identification
- Full name
- Liliana Santos
Citation names
- Santos, Liliana
- Santos, L
Author identifiers
- Ciência ID
- 5E1A-2C3C-DBB8
- ORCID iD
- 0000-0003-2525-9572
Languages
Language | Speaking | Reading | Writing | Listening | Peer-review |
---|---|---|---|---|---|
Portuguese (Mother tongue) | |||||
French | Intermediate (B1) | Intermediate (B1) | Intermediate (B1) | Intermediate (B1) | Intermediate (B1) |
English | Upper intermediate (B2) | Upper intermediate (B2) | Upper intermediate (B2) | Upper intermediate (B2) | Upper intermediate (B2) |
Education
Degree | Classification | |
---|---|---|
2020/07 - 2025/01/22
Concluded
|
Drugs R&D doctoral PhD program (Doutoramento)
Universidade de Coimbra Faculdade de Farmácia, Portugal
"Uncovering the mechanisms behind blood-brain barrier dysfunction in HER2+ breast cancer brain metastasis: a step toward new
therapeutic approaches" (THESIS/DISSERTATION)
|
|
2019/11/04 - 2019/11/15
Concluded
|
III Modular Training in Laboratory Animal Science (Outros)
Major in Especialização em Function A
Universidade de Coimbra, Portugal
|
17.3 |
2015/09 - 2017/12
Concluded
|
Oncologia (Mestrado)
Major in Oncologia molecular
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
"Role of Mitochondrial Dynamics in Hürthle Cell Tumors: Coupling, Uncoupling and Fission" (THESIS/DISSERTATION)
|
18 |
2012/09 - 2015/07
Concluded
|
Bioquímica (Licenciatura)
Universidade de Trás-os-Montes e Alto Douro, Portugal
|
15 |
Affiliation
Others
Category Host institution |
Employer | |
---|---|---|
2024/10 - Current | Research fellow (Project: CHAngeing – Connected Hubs in Ageing: Healthy Living to Protect Cerebrovascular Function) | CNC.IBILI, Portugal |
2020/07 - 2025/01 | PhD Student in Drugs R&D doctoral programme | Universidade de Coimbra Faculdade de Farmácia, Portugal |
2019/10/01 - 2020/03/31 | Research fellow (Project: BrainHealth 2020 – Early detection, neuromodulation and advance therapies for neuropathologies) | CNC.IBILI, Portugal |
2018/05/01 - 2019/09/30 | Research Fellow (Project: Tackling CANcer STEM CELls: a challenge and an opportunity to advance in anti-cancer therapy) | CNC.IBILI, Portugal |
2016/04 - 2018/03 | MSc student | Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal |
Projects
Contract
Designation | Funders | |
---|---|---|
2024/10 - Current | CHAngeing – Connected Hubs in Ageing: Healthy Living to Protect Cerebrovascular Function
101087071
Research Fellow
CNC.IBILI, Portugal
|
|
2019/10/01 - 2020/03/31 | BrainHealth 2020 – Early detection, neuromodulation and advance therapies for neuropathologies
CENTRO-01-0145-FEDER-000008
Research Fellow
CNC.IBILI, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2018/05/01 - 2019/09/30 | Tackling CANcer STEM CELls: a challenge and an opportunity to advance in anti-cancer therapy
SAICTPAC/0022/2015
Research Fellow
CNC.IBILI, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
Outputs
Publications
Book chapter |
|
Conference poster |
|
Journal article |
|
Preprint |
|
Thesis / Dissertation |
|
Activities
Oral presentation
Presentation title | Event name Host (Event location) |
|
---|---|---|
2025/02 | ENPP1 induces blood-brain barrier dysfunction and promotes brain metastasis formation in HER2+ breast cancer | V Metabolism, Ageing & Disease (MAD) Meeting
(Coimbra, Portugal)
|
2024/12 | Tumor-secreted ENPP1 modulates BBB dysfunction during early brain metastatic progression | CiBB meeting 2024
(Coimbra, Portugal)
|
2024/06 | Disfunção da barreira hematoencefálica na metastização cerebral em cancro da mama | II PhDoing: Da Pipeta ao Estetoscópio
(Coimbra, Portugal)
|
2024/01 | Impact of HER2+ brain-tropic breast cancer cells in blood-brain barrier dysfunction during the premetastatic niche formation | IV Metabolism, Ageing & Disease (MAD) Meeting Disease & Therapeutics: from the Past to Future
(Coimbra, Portugal)
|
2023/10 | Impact of HER2+ brain-tropic breast cancer cells in blood-brain barrier dysfunction during the premetastatic niche formation | ASPIC-ASEICA 2023
(Porto, Portugal)
|
2023/10 | Therapeutic Efficacy of [177Lu]Lu-DOTA-Trastuzumab in Trastuzumab-resistant HER2-Positive metastatic lesions | “Optimizing Imaging and Dose-Response in RadiotherapieS“ workshop
(Erquy, France)
|
2023/02 | Trastuzumab-resistant HER2+ brain-tropic breast cancer cells interfere with the blood-brain barrier permeability: a potential route for brain drug delivery | SPF 2023
(Coimbra, Portugal)
|
2022/09/21 | Impact of HER2+ Brain-Tropic Breast Cancer Cells in Blood-Brain Barrier Permeability | Blood Brain Barriers 2022
(Bari)
|
2020 | VGF-secreted peptide derived from brain metastatic breast cancer cells induces brain endothelial cells dysfunction | SPF 2020 - 50.ª Reunião da Sociedade Portuguesa de Farmacologia, 38.ª Reunião de Farmacologia Clínica e 19.ª Reunião de Toxicologia
(Coimbra, Portugal)
|
2018/02 | Role of Mitochondrial Dynamics in Hürthle Cell Tumors: Coupling, Uncoupling and Fission | Encontro de Investigação jovem da Universidade do Porto - IJUP
(Porto, Portugal)
|
2017/11 | Role of Mitochondrial Dynamics in Hürthle Cell Tumors: Coupling, Uncoupling and Fission; | 6th i3S Annual meeting
(Porto)
|
Association member
Society Organization name | Role | |
---|---|---|
2016 - Current | ASPIC and EACR member | Sócio |
Distinctions
Award
2024 | Flash talk award: Impact of HER2+ brain-tropic breast cancer cells in blood-brain barrier dysfunction during the premetastatic niche formation |
2024 | Best Flash Talk: Tumor-secreted ENPP1 modulates BBB dysfunction during early brain metastatic progression |
2023 | Best Oral Presentation Award: Impact of HER2+ brain-tropic breast cancer cells in blood-brain barrier dysfunction during the
premetastatic niche formation
Associação Portuguesa de Investigação em Cancro, Portugal
Asociación Española de Investigación sobre el Cáncer, Spain |
2022 | EACR Poster Prize: Trastuzumab-resistant HER2+ Brain Tropic Breast Cancer Cells Disrupt the Blood-Brain Barrier: a Potential
Route for Brain Drug Delivery
European Association For Cancer Research, United Kingdom
|